NAS
IMVT icon

Nykredit A/S’s Immunovant IMVT Stock Holding History

Nykredit A/S’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$174K Buy
+4,504
New +$137K ﹤0.01% 1092

Other funds holding IMVT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nykredit A/S's IMVT Position: Q2 2026 in Review

Nykredit A/S opened a new position in Immunovant (IMVT) in Q2 2026: 4,504 shares worth $174K. The stake represents ﹤0.01% of the portfolio and ranks #1092 among its holdings.

152 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Nykredit A/S held 4,504 shares of Immunovant worth $174K as of Q2 2026.
  • Immunovant was a new Nykredit A/S position in Q2 2026.
  • Immunovant made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1092 holding.
  • 152 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.